Home / Emtricitabine / United States
US ATC J05AF09 · updated 2 Nov 2026
Emtricitabine shortage in United States
Is there an Emtricitabine shortage in United States?
Yes. As of 2 Nov 2026, 2 Emtricitabine products are reported short in United States, the first since 17 Jun 2026. No return date has been given. Main reason: not stated.
Also short in Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Emtriva, Capsule, 200 mg (NDC 61958-0601-1) discontinuation | Gilead Sciences, Inc. | 17 Jun 2026 | not given | Not stated |
| US | Emtriva, Oral Solution, 10 mg/1 mL (NDC 61958-0602-1) discontinuation | Gilead Sciences, Inc. | 17 Jun 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).